Cerity Partners’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Buy |
6,541
+190
| +3% | +$9.24K | ﹤0.01% | 2124 |
|
|
2025
Q1 | $216K | Buy |
+6,351
| New | +$216K | ﹤0.01% | 2176 |
|
|
2022
Q2 | – | Sell |
-3,818
| Closed | -$239K | – | 1190 |
|
|
2022
Q1 | $239K | Buy |
3,818
+9
| +0.2% | +$563 | ﹤0.01% | 809 |
|
|
2021
Q4 | $289K | Buy |
3,809
+1,360
| +56% | +$103K | ﹤0.01% | 780 |
|
|
2021
Q3 | $274K | Hold |
2,449
| – | – | 0.01% | 583 |
|
|
2021
Q2 | $396K | Hold |
2,449
| – | – | 0.01% | 516 |
|
|
2021
Q1 | $298K | Buy |
+2,449
| New | +$298K | 0.01% | 559 |
|